It is a skeletal muscle relaxant used in addition to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Skin flushing or redness, injection site reactions, hives, itching, wheezing, shortness of breath, allergic reactions, fast or slow heart rate, low blood pressure and inadequate musculoskeletal block.

It is contraindicated in patients with known hypersensitivity to the drug.

Use with caution in patients with clinically significant cardiovascular disease

Donot give this injection by intramuscular administration

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenousinfusion through the same needle. Depending on the resultant pH of such mixtures, atracurium may be inactivated and a free acid may be precipitated.

Atracurium has no known effect on consciousness, pain threshold, or cerebration. It should be used only with adequate anesthesia.

Please consult your doctor when taking this medicine if you are pregnant.

Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine.